Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 4/2016

07.10.2015

Derivation of a risk assessment model for hospital-acquired venous thrombosis: the NAVAL score

verfasst von: Marcos de Bastos, Sandhi M. Barreto, Jackson S. Caiafa, Tânia Boguchi, José Luiz Padilha Silva, Suely M. Rezende

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Venous thrombosis (VT) is a preventable cause of death in hospitalized patients. The main strategy to decrease VT incidence is timely thromboprophylaxis in at-risk patients. We sought to evaluate the reliability of risk assessment model (RAM) data, the incremental usefulness of additional variables and the modelling of an adjusted score (the NAVAL score). We used the RAM proposed by Caprini for initial assessment. A 5 % systematic sample of data was independently reviewed for reliability. We evaluated the incremental usefulness of six variables for VT during the score modelling by logistic regression. We then assessed the NAVAL score for calibration, reclassification and discrimination performances. We observed 11,091 patients with 37 (0.3 %) VT events. Using the Caprini RAM, high-risk and moderate-risk patients were respectively associated with a 17.4 (95 % confidence interval [CI] 6.1–49.9) and 4.2 (95 % CI 1.6–11.0) increased VT risk compared with low-risk patients. Four independent variables were selected for the NAVAL score: “Age”, “Admission clinic”, “History of previous VT event” and “History of thrombophilia”. The area under the receiver-operating-characteristic curve for the NAVAL score was 0.72 (95 % CI 0.63–0.81). The Net Reclassification Index (NRI) for the NAVAL score compared with the Caprini RAM was −0.1 (95 % CI −0.3 to 0.1; p = 0.28). We conclude that the NAVAL score is a simplified tool for the stratification of VT risk in hospitalized patients. With only four variables, it demonstrated good performance and discrimination, but requires external validation before clinical application. We also confirm that the Caprini RAM can effectively stratify VT risk in hospitalized patients in our population.
Literatur
1.
Zurück zum Zitat Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ (2001) Making health care safer: a critical analysis of patient safety practices. AHCRQ, Rockville, pp 332–346 Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ (2001) Making health care safer: a critical analysis of patient safety practices. AHCRQ, Rockville, pp 332–346
2.
Zurück zum Zitat Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al (2008) American College of Chest Physicians. Prevention of venous thromboembolism. American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133:381S–453SCrossRefPubMed Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al (2008) American College of Chest Physicians. Prevention of venous thromboembolism. American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133:381S–453SCrossRefPubMed
3.
Zurück zum Zitat Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M et al (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 132:936–945CrossRefPubMed Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M et al (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 132:936–945CrossRefPubMed
5.
Zurück zum Zitat Bastos M, Barreto SM, Caiafa JS, Rezende SM (2011) Thromboprophylaxis: medical recommendations and hospital programs. Rev Assoc Med Bras 57(1):88–99CrossRefPubMed Bastos M, Barreto SM, Caiafa JS, Rezende SM (2011) Thromboprophylaxis: medical recommendations and hospital programs. Rev Assoc Med Bras 57(1):88–99CrossRefPubMed
6.
Zurück zum Zitat Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) American College of Chest Physicians. Prevention of VT in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):227S–277SCrossRef Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al (2012) American College of Chest Physicians. Prevention of VT in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):227S–277SCrossRef
7.
Zurück zum Zitat Evans RS, Lloyd JF, Aston VT, Woller SC, Tripp JS, Elliott CG et al. Computer surveillance of patients at high risk for and with venous thromboembolism. In: AMIA Annual Symposium Proceedings, vol 2010. American Medical Informatics Association, Bethesda, pp 217–221 Evans RS, Lloyd JF, Aston VT, Woller SC, Tripp JS, Elliott CG et al. Computer surveillance of patients at high risk for and with venous thromboembolism. In: AMIA Annual Symposium Proceedings, vol 2010. American Medical Informatics Association, Bethesda, pp 217–221
8.
Zurück zum Zitat Bagot C, Gohil S, Perrott R, Barsam S, Patel RK, Arya R (2010) The use of an exclusion-based risk-assessment model for venous thrombosis improves uptake of appropriate thromboprophylaxis in hospitalized medical patients. QJM 103(8):597–605CrossRefPubMed Bagot C, Gohil S, Perrott R, Barsam S, Patel RK, Arya R (2010) The use of an exclusion-based risk-assessment model for venous thrombosis improves uptake of appropriate thromboprophylaxis in hospitalized medical patients. QJM 103(8):597–605CrossRefPubMed
9.
Zurück zum Zitat Caiafa JS, Bastos M (2002) Programa de profilaxia do tromboembolismo venoso do Hospital Naval Marcílio Dias: um modelo de educação continuada. J Vasc Br 1(2):103–112 Caiafa JS, Bastos M (2002) Programa de profilaxia do tromboembolismo venoso do Hospital Naval Marcílio Dias: um modelo de educação continuada. J Vasc Br 1(2):103–112
10.
Zurück zum Zitat Caiafa JS, de Bastos M, Moura LK, Raymundo S (2002) Brazilian Registry of venous thromboembolism prophylaxis. Managing venous thromboembolism in Latin American patients: emerging results from the Brazilian Registry. Semin Thromb Hemost 28(Suppl 3):47–50CrossRefPubMed Caiafa JS, de Bastos M, Moura LK, Raymundo S (2002) Brazilian Registry of venous thromboembolism prophylaxis. Managing venous thromboembolism in Latin American patients: emerging results from the Brazilian Registry. Semin Thromb Hemost 28(Suppl 3):47–50CrossRefPubMed
11.
Zurück zum Zitat Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F (1991) Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 17(Suppl 3):304–312PubMed Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F (1991) Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 17(Suppl 3):304–312PubMed
12.
Zurück zum Zitat Arcelus JI, Candocia S, Traverso CI, Fabrega F, Caprini JA, Hasty JH (1991) Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost 17(Suppl 3):313–318PubMed Arcelus JI, Candocia S, Traverso CI, Fabrega F, Caprini JA, Hasty JH (1991) Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost 17(Suppl 3):313–318PubMed
13.
Zurück zum Zitat Streiff MB, Carolan HT, Hobson DB, Kraus PS, Holzmueller CG, Demski R et al (2012) Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 344:e3935CrossRefPubMedPubMedCentral Streiff MB, Carolan HT, Hobson DB, Kraus PS, Holzmueller CG, Demski R et al (2012) Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 344:e3935CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat de Bastos M, Barreto SM, Caiafa JS, Bogutchi T, Rezende SM (2013) Assessment of characteristics associated with pharmacologic thromboprophylaxis use in hospitalized patients: a cohort study of 10,016 patients. Blood Coagul Fibrinolysis 24:691–697CrossRefPubMed de Bastos M, Barreto SM, Caiafa JS, Bogutchi T, Rezende SM (2013) Assessment of characteristics associated with pharmacologic thromboprophylaxis use in hospitalized patients: a cohort study of 10,016 patients. Blood Coagul Fibrinolysis 24:691–697CrossRefPubMed
15.
Zurück zum Zitat Hirsh J, Hoak J (1996) Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals from the council on thrombosis (in consultation with the Council on Cardiovascular Radiology). Circulation 93:2212–2245CrossRefPubMed Hirsh J, Hoak J (1996) Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals from the council on thrombosis (in consultation with the Council on Cardiovascular Radiology). Circulation 93:2212–2245CrossRefPubMed
16.
Zurück zum Zitat Petrie A, Sabin C (2009) Medical statistics at a glance, 3rd edn. Wiley-Blackwell, Oxford Petrie A, Sabin C (2009) Medical statistics at a glance, 3rd edn. Wiley-Blackwell, Oxford
17.
Zurück zum Zitat Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination. Nephrol Dial Transplant 25:1399–1401CrossRefPubMed Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination. Nephrol Dial Transplant 25:1399–1401CrossRefPubMed
18.
Zurück zum Zitat Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Statistical methods for the assessment of prognostic biomarkers (part II): calibration and reclassification. Nephrol Dial Transplant 25:1402–1405CrossRefPubMed Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Statistical methods for the assessment of prognostic biomarkers (part II): calibration and reclassification. Nephrol Dial Transplant 25:1402–1405CrossRefPubMed
19.
Zurück zum Zitat Zhou H, Wang L, Wu X, Tang Y, Yang J, Wang B et al (2014) Validation of a venous thromboembolism risk assessment model in hospitalized chinese patients: a case-control study. J Atheroscler Thromb 21:261–272CrossRefPubMed Zhou H, Wang L, Wu X, Tang Y, Yang J, Wang B et al (2014) Validation of a venous thromboembolism risk assessment model in hospitalized chinese patients: a case-control study. J Atheroscler Thromb 21:261–272CrossRefPubMed
20.
Zurück zum Zitat Caprini JA (2005) Thrombosis risk assessment as a guide to quality patient care. Dis Mon 51:70–78CrossRefPubMed Caprini JA (2005) Thrombosis risk assessment as a guide to quality patient care. Dis Mon 51:70–78CrossRefPubMed
21.
Zurück zum Zitat Maynard G, Stein J (2010) Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis 29:159–166CrossRefPubMedPubMedCentral Maynard G, Stein J (2010) Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis 29:159–166CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW, Jaber RM et al (2011) Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg 212:105–112CrossRefPubMedPubMedCentral Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW, Jaber RM et al (2011) Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg 212:105–112CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA (2010) A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 251(2):344–350CrossRefPubMed Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA (2010) A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 251(2):344–350CrossRefPubMed
24.
Zurück zum Zitat Spyropoulos AC, Anderson FA Jr, Fitzgerald G, Decousus H, Pini M, Chong BH et al (2011) Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140(3):706–714CrossRefPubMed Spyropoulos AC, Anderson FA Jr, Fitzgerald G, Decousus H, Pini M, Chong BH et al (2011) Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140(3):706–714CrossRefPubMed
25.
Zurück zum Zitat Millar JA (2008) Rational thromboprophylaxis in medical inpatients: not quite there yet. Med J Aust 189(9):504–506PubMed Millar JA (2008) Rational thromboprophylaxis in medical inpatients: not quite there yet. Med J Aust 189(9):504–506PubMed
26.
Zurück zum Zitat Bikdeli B, Sharif-Kashani B, Shahabi P, Raeissi S, Shahrivari M, Shoraka AR et al (2013) Comparison of three risk assessment methods for venous thromboembolism prophylaxis. Blood Coagul Fibrinolysis 24(2):157–163PubMed Bikdeli B, Sharif-Kashani B, Shahabi P, Raeissi S, Shahrivari M, Shoraka AR et al (2013) Comparison of three risk assessment methods for venous thromboembolism prophylaxis. Blood Coagul Fibrinolysis 24(2):157–163PubMed
27.
Zurück zum Zitat Woller SC, Stevens SM, Jones JP, Lloyd JF, Evans RS, Aston VT et al (2011) Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med 124(10):947–954CrossRefPubMed Woller SC, Stevens SM, Jones JP, Lloyd JF, Evans RS, Aston VT et al (2011) Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med 124(10):947–954CrossRefPubMed
28.
Zurück zum Zitat Rosenberg D, Eichorn A, Alarcon M, McCullagh L, McGinn T, Spyropoulos AC (2014) External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system. J Am Heart Assoc. 3(6):e001152CrossRefPubMedPubMedCentral Rosenberg D, Eichorn A, Alarcon M, McCullagh L, McGinn T, Spyropoulos AC (2014) External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system. J Am Heart Assoc. 3(6):e001152CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Huang W, Anderson FA, Spencer FA, Gallus A, Goldberg RJ (2013) Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review. J Thromb Thrombolysis 35(1):67–80CrossRefPubMed Huang W, Anderson FA, Spencer FA, Gallus A, Goldberg RJ (2013) Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review. J Thromb Thrombolysis 35(1):67–80CrossRefPubMed
30.
Zurück zum Zitat Spyropoulos AC, McGinn T, Khorana AA (2012) The use of weighted and scored risk assessment models for venous thromboembolism. Thromb Haemost 108(6):1072–1076CrossRefPubMed Spyropoulos AC, McGinn T, Khorana AA (2012) The use of weighted and scored risk assessment models for venous thromboembolism. Thromb Haemost 108(6):1072–1076CrossRefPubMed
31.
Zurück zum Zitat Psaty BM, Koepsell TD, Lin D, Weiss NS, Siscovick DS, Rosendaal FR et al (1999) Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 47(6):749–754CrossRefPubMed Psaty BM, Koepsell TD, Lin D, Weiss NS, Siscovick DS, Rosendaal FR et al (1999) Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 47(6):749–754CrossRefPubMed
32.
Zurück zum Zitat Concato J, Feinstein AF, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201–210CrossRefPubMed Concato J, Feinstein AF, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201–210CrossRefPubMed
33.
Zurück zum Zitat Courvoisier DS, Combescure C, Agoritsas T, Gayet-Ageron A, Perneger TV (2011) Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure. J Clin Epidemiol 64(9):993–1000CrossRefPubMed Courvoisier DS, Combescure C, Agoritsas T, Gayet-Ageron A, Perneger TV (2011) Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure. J Clin Epidemiol 64(9):993–1000CrossRefPubMed
Metadaten
Titel
Derivation of a risk assessment model for hospital-acquired venous thrombosis: the NAVAL score
verfasst von
Marcos de Bastos
Sandhi M. Barreto
Jackson S. Caiafa
Tânia Boguchi
José Luiz Padilha Silva
Suely M. Rezende
Publikationsdatum
07.10.2015
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 4/2016
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-015-1277-4

Weitere Artikel der Ausgabe 4/2016

Journal of Thrombosis and Thrombolysis 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.